title: Momentum builds around new antibiotic business models.
authors.forename: Asher
authors.initials: A
authors.lastname: Mullard
mesh_terms: D000900:Anti-Bacterial Agents / Q000191:economics*; D003132:Commerce; D015195:Drug Design; D004345:Drug Industry / Q000191:economics / Q000458:organization & administration*; D006801:Humans; D012051:Reimbursement Mechanisms
chemical_list: D000900:Anti-Bacterial Agents